SecurityCRIS / Curis, Inc. (231269101)
President & CEOFattaey Ali Ph.D.
IndustryBiological Products, Except Diagnostic Substances (Biotech)
Institutional Owners95
Institutional Shares75,657,884 - 45.68%
Common Shares Outstanding165,628,371 shares (as of 2018-03-31)
Institutional Value$ 98,306,000 USD

Institutional Stock Ownership and Shareholders

CRIS / Curis, Inc. Institutional Ownership

Curis, Inc. (NASDAQ:CRIS) has 95 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 75,657,884 shares. Largest shareholders include First Eagle Investment Management, LLC, BlackRock Inc., Vanguard Group Inc, BlackRock Fund Advisors, Renaissance Technologies LLC, BlackRock Institutional Trust Company, N.A., Arnhold Llc, State Street Corp, Gsa Capital Partners Llp, and Deutsche Bank Ag\.
Curis, Inc. (NASDAQ:CRIS) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/cris"><img src="https://images.fintel.io/us-cris-so.png" alt="CRIS / Curis, Inc. Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-15 13F-HR SILVERCREST ASSET MANAGEMENT GROUP LLC 30,000 30,000 0.00 21 20 -4.76
2018-05-14 13F-HR DRW Securities, LLC 50,000 50,000 0.00 35 33 -5.71
2018-05-09 13F-HR Candriam Luxembourg S.C.A. 800,000 523
2018-05-15 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 208,456 208,456 0.00 146 136 -6.85
2018-05-14 13F-HR TEACHERS ADVISORS INC 220,263 220,263 0.00 154 144 -6.49
2018-05-15 13F-HR AQR CAPITAL MANAGEMENT LLC 642,323 468,984 -26.99 450 306 -32.00
2018-05-09 13F-HR Cambridge Investment Research Advisors, Inc. 22,500 15
2018-05-10 13F-HR FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. 12,950 12,950 0.00 9 8 -11.11
2018-04-19 13F-HR Janney Montgomery Scott LLC 92,600 86,600 -6.48 65 57 -12.31
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 3,086,564 3,151,913 2.12 8,056 9,708 20.51
2018-05-15 13F-HR Voya Investment Management LLC 59,413 59,413 0.00 42 39 -7.14
2018-05-15 13F-HR DEUTSCHE BANK AG\ 470,799 1,593,338 238.43 328 1,039 216.77
2018-05-11 13F-HR BNP PARIBAS ARBITRAGE, SA 35,793 40,597 13.42 25,055 26,522 5.86
2018-05-15 13F-HR PANAGORA ASSET MANAGEMENT INC 806,793 641,221 -20.52 565 419 -25.84
2018-05-15 13F-HR PERCEPTIVE ADVISORS LLC 951,201 0 -100.00 666 0 -100.00
2018-05-14 13F-HR Renaissance Technologies LLC 1,331,900 3,949,600 196.54 932 2,580 176.82
2018-05-14 13F-HR MERIDIAN INVESTMENT COUNSEL INC. 10,000 10,000 0.00 7 7 0.00
2018-05-03 13F-HR MEEDER ASSET MANAGEMENT INC 1,555 1,684 8.30 1 1 0.00
2018-05-14 13F-HR ProShare Advisors LLC 107,976 92,722 -14.13 76 61 -19.74
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 0 55,500 0 36
2018-05-15 13F-HR BROOKSIDE CAPITAL MANAGEMENT LLC 633,621 576,591 -9.00 444 377 -15.09
2018-05-15 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 2,306 2,768 20.03 2 2 0.00
2018-05-15 13F-HR GUGGENHEIM CAPITAL LLC 0 16,492 0 10
2017-02-10 13F-HR BlackRock Investment Management, LLC 454,596 452,808 -0.39 1,186 1,395 17.62
2018-05-03 13F-HR AMERICAN CENTURY COMPANIES INC 12,996 12,996 0.00 9 8 -11.11
2018-05-08 13F-HR THRIVENT FINANCIAL FOR LUTHERANS 153,708 0 -100.00 108 0 -100.00
2018-05-15 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 380,660 0 -100.00 266 0 -100.00
2018-05-15 13F-HR D. E. Shaw & Co., Inc. 869,923 827,783 -4.84 609 541 -11.17
2018-04-26 13F-HR SIMPLEX TRADING, LLC Call 13 68 423.08 0 0
2018-04-12 13F-HR Valeo Financial Advisors, Llc 48 48 0.00 0 0
2018-05-15 13F-HR Sio Capital Management, LLC 834,551 545
2018-05-11 13F-HR Arnhold Llc 2,918,753 1,907
2018-05-15 13F-HR Bank of New York Mellon Corp 361,445 380,559 5.29 253 249 -1.58
2018-05-15 13F-HR BARCLAYS PLC 35,078 29,917 -14.71 25 19 -24.00
2018-05-14 13F-HR Baird Financial Group, Inc. 2,976,021 45,749 -98.46 2,083 30 -98.56
2018-05-15 13F-HR Invesco Ltd. 0 10,446 0 7
2018-05-15 13F-HR TWO SIGMA INVESTMENTS LLC 854,944 600,592 -29.75 598 392 -34.45
2018-04-18 13F-HR/A FNY Partners Fund LP 10,000 10,000 0.00 7 6 -14.29
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 119,879 91,122 -23.99 84 59 -29.76
2018-05-11 13F-HR GSA CAPITAL PARTNERS LLP 937,057 1,913,208 104.17 656 1,250 90.55
2018-05-02 13F-HR Daiwa Securities Group Inc. 906 1
2018-04-18 13F-HR Creative Planning 21,000 21,000 0.00 15 14 -6.67
2018-05-14 13F-HR ALLIANCEBERNSTEIN L.P. 60,500 60,500 0.00 42 40 -4.76
2018-05-14 13F-HR AMERIPRISE FINANCIAL INC 33,680 34,080 1.19 24 22 -8.33
2018-05-08 13F-HR Geneva Partners, Llc 20,000 20,000 0.00 14 13 -7.14
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 56,946 11,832 -79.22 40 8 -80.00
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 532,877 481,815 -9.58 372 315 -15.32
2018-05-15 13F-HR Squarepoint Ops LLC 18,200 0 -100.00 13 0 -100.00
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 504,371 194,390 -61.46 353 127 -64.02
2018-05-15 13F-HR HONKAMP KRUEGER FINANCIAL SERVICES INC /ADV 635 0
2018-05-15 13F-HR DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 127,096 83
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 29,192 5,362 -81.63 21 4 -80.95
2018-04-24 13F-HR McAdam, LLC 36 0
2018-05-15 13F-HR VANGUARD GROUP INC 6,303,688 5,931,945 -5.90 4,413 3,875 -12.19
2018-04-12 13F-HR ACADIAN ASSET MANAGEMENT LLC 211,779 139
2018-04-16 13F-HR Raymond James Financial Services Advisors, Inc. 11,060 0 -100.00 8 0 -100.00
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. Call 1,500 27,900 1,760.00 1 18 1,700.00
2018-05-07 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 222,354 222,354 0.00 156 146 -6.41
2018-05-14 13F-HR Bayesian Capital Management, LP 77,900 51
2017-02-10 13F-HR BlackRock Fund Advisors 4,840,136 5,551,378 14.69 12,633 17,098 35.34
2018-05-07 13F-HR STATE OF WISCONSIN INVESTMENT BOARD 86,000 86,000 0.00 60 56 -6.67
2018-05-04 13F-HR First Eagle Investment Management, LLC 27,758,672 24,904,977 -10.28 19,431 16,270 -16.27
2018-05-07 13F-HR Focused Wealth Management, Inc 184,490 184,490 0.00 129 121 -6.20
2018-05-09 13F-HR BlackRock Inc. 9,719,497 9,609,573 -1.13 6,803 6,278 -7.72
2018-05-15 13F-HR STATE STREET CORP 1,875,299 1,993,216 6.29 1,314 1,300 -1.07
2018-05-07 13F-HR AMERICAN INTERNATIONAL GROUP INC 89,079 84,533 -5.10 62 55 -11.29
2018-05-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 294,522 644,660 118.88 206 421 104.37
2018-05-15 13F-HR TWO SIGMA ADVISERS, LP 331,922 478,123 44.05 232 312 34.48
2018-05-11 13F-HR CITIGROUP INC 18,558 17,529 -5.54 13 11 -15.38
2018-04-27 13F-HR Chicago Partners Investment Group LLC 100 0
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 1,047,295 1,056,741 0.90 733 690 -5.87
2018-05-09 13F-HR NORTHERN TRUST CORP 1,442,140 1,442,210 0.00 1,010 942 -6.73
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 210,300 210,300 0.00 147 137 -6.80
2018-04-26 13F-HR SIMPLEX TRADING, LLC 804 1,900 136.32 0 1
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 321,400 14,532 -95.48 225 9 -96.00
2018-05-14 13F-HR MACKENZIE FINANCIAL CORP 36,008 24
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. 17,167 12,167 -29.13 12 8 -33.33
2017-05-15 13F-HR R&F Capital Advisors LP 13,802 0 -100.00 43 0 -100.00
2018-05-15 13F-HR Walleye Trading LLC 0 81,632 0 53
2018-05-10 13F-HR WIMMER ASSOCIATES 1, LLC 10,000 10,000 0.00 7 7 0.00
2017-02-10 13F-HR BlackRock Advisors LLC 57,569 60,578 5.23 150 187 24.67
2018-04-10 13F-HR Gierl Augustine Investment Management Inc 9,500 9,500 0.00 7 6 -14.29
2018-04-20 13F-HR STRS OHIO 48,500 48,500 0.00 33 31 -6.06
2018-05-15 13F-HR CREDIT SUISSE AG/ 47,453 57,506 21.19 34 37 8.82
2018-05-22 13F-HR AMALGAMATED BANK 18,716 16,703 -10.76 13 11 -15.38
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 16,820 0 -100.00 12 0 -100.00
2018-05-15 13F-HR UBS Group AG 43,895 12,786 -70.87 30 8 -73.33
2018-05-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 101,500 101,500 0.00 71 66 -7.04
2018-05-14 13F-HR Virtu Financial LLC 98,444 113,990 15.79 69 74 7.25
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. 17,598 0 -100.00 12 0 -100.00
2017-02-08 13F-HR Geduld E E 10,000 10,000 0.00 26 31 19.23
2018-05-15 13F-HR JACOBS LEVY EQUITY MANAGEMENT, INC 452,099 0 -100.00 316 0 -100.00
2018-05-11 13F-HR CITADEL ADVISORS LLC 14,532 9
2018-05-14 13F-HR UNITED SERVICES AUTOMOBILE ASSOCIATION 19,155 13
2018-05-15 13F-HR Spectrum Financial Alliance Ltd Llc 1,075 0
2018-05-14 13F-HR NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 0 8,000 0 5
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. Put 5,000 0 -100.00 4 0 -100.00
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 30 2,000 6,566.67 0 1
2018-05-02 13F-HR RHUMBLINE ADVISERS 107,374 107,374 0.00 75 70 -6.67
2018-05-14 13F-HR MORGAN STANLEY 479,049 373,539 -22.02 336 244 -27.38
2018-05-10 13F-HR JP Morgan Chase & Co 2,352,082 26,623 -98.87 1,647 17 -98.97
2018-05-14 13F-HR FMR LLC / Fidelity 7,206,044 0 -100.00 5,044 0 -100.00
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 3,149,154 0 -100.00 2,204 0 -100.00
2017-02-07 13F-HR FIRST NEW YORK SECURITIES LLC /NY 12,000 0 -100.00 31,320 0 -100.00
2018-05-11 13F-HR MACQUARIE GROUP LTD 11,000 0 -100.00 8 0 -100.00
2018-05-15 13F-HR OXFORD ASSET MANAGEMENT 222,774 15,831 -92.89 163 10 -93.87
2018-05-15 13F-HR Ameritas Investment Partners, Inc. 8,583 8,583 0.00 6 6 0.00
2018-05-15 13F-HR Telemetry Investments, L.L.C. 292,000 286,000 -2.05 204 187 -8.33
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 70,341 70,822 0.68 49 46 -6.12
2018-05-14 13F-HR BB&T SECURITIES, LLC 96,522 96,522 0.00 67 63 -5.97
2018-05-15 13F-HR Weiss Multi-Strategy Advisers LLC 125,000 120,800 -3.36 88 79 -10.23
2018-05-17 13F-HR Legal & General Group Plc 40,285 27,620 -31.44 28 18 -35.71
2018-05-03 13F-HR SG Americas Securities, LLC 269,128 62,022 -76.95 188 41 -78.19

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

Related News Stories

Curis' (CRIS) CEO Ali Fattaey on Q1 2018 Results - Earnings Call Transcript

2018-05-03 seekingalpha
Good morning, and welcome to the Curis First Quarter 2018 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. (27-2)

Curis: Time To Bet On A Courageous Choice

2018-03-20 seekingalpha
Aurigene (the company that created CA-170) has started a Phase 2 trial in multiple centers in India. (27-4)

CUSIP: 231269101